3 completed, 2 unknown, 1 active not recruiting. 6 Phase 4.
| Phase | Trials | Status |
|---|---|---|
| Phase 4 | 6 | Completed 3, Unknown 2, Active not recruiting 1 |
Follow Conbercept: new trials by email Literature Review of Conbercept trials Research Report on Conbercept
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Efficacy and Safety of Conbercept for Diabetic Macular Edema Combined With Severe Non-proliferative Diabetic Retinopathy Conbercept - Diabetic Macular Edema | Phase 4 | Active not recruiting | Shanghai Eye Disease Prevention and Treatment Center | 58 | 2024-04-01 | 2025-05-30 |
| Initial Versus Delayed PDT Combination With Conbercept in PCV conbercept, Initial PDT, Delayed PDT - Polypoidal Choroidal Vasculopathy | Phase 4 | Completed | The Eye Hospital of Wenzhou Medical University | 80 | 2017-01-01 | 2019-07-19 |
| Efficacy and Safety of "Treat-and-Extend" Regimen Versus "Pro Re Nata" of Conbercept in Age-related Macular Degeneration Treat-and-Extend regimen, Pro Re Nata, Conbercept - Age-related Macular Degeneration | Phase 4 | Unknown | Xiaodong Sun | 141 | 2016-09-01 | 2020-05-19 |
| Conbercept Injection in Treatment of Severe Proliferative Diabetic Retinopathy Conbercept - Proliferative Diabetic Retinopathy, Tractional Retinal Detachment | Phase 4 | Completed | Ruijin Hospital | 112 | 2016-07-01 | 2019-11-21 |
| Head to Head Study of Anti-VEGF Treatment. ranibizumab, Conbercept - Age-related Macular Degeneration | Phase 4 | Completed | Novartis Pharmaceuticals | 12 | 2016-01-13 | 2017-11-30 |
| The Efficacy Assessment of Intravitreal Injection of Conbercept in Patients With Polypoidal Choroidal Vasculopathy (PCV) Conbercept - Polypoidal Choroidal Vasculopathy (PCV) | Phase 4 | Unknown | Chengdu Kanghong Biotech Co., Ltd. | 300 | 2015-10-01 | 2017-07-19 |
Macular Degeneration (2) · Polypoidal Choroidal Vasculopathy (2)
Chengdu Kanghong Biotech Co., Ltd. (1) · Novartis Pharmaceuticals (1) · Ruijin Hospital (1) · Shanghai Eye Disease Prevention and Treatment Center (1) · The Eye Hospital of Wenzhou Medical University (1) · Xiaodong Sun (1)
China (6)
Tao Sun (1) · Xi Shen, PhD (1) · Xiaodong Sun (1) · Xiaoling Liu, Professor (1)